GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 12801 - 12850 of 39437 in total
PDB ID ▼ UniProt ID Title Descriptor
7L8F Q2N0S5 BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-2 from animal Rh.33172 (Wk38 time point)
7L8F 7L8F BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-2 from animal Rh.33172 (Wk38 time point)
7L8E Q2N0S5 BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-1 from animal Rh.33172 (Wk38 time point)
7L8E 7L8E BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-1 from animal Rh.33172 (Wk38 time point)
7L8D 7L8D BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.33104 (Wk26 time point)
7L8C 7L8C BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.33104 (Wk26 time point)
7L8B 7L8B BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.33104 (Wk26 time point)
7L8A 7L8A BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.33104 (Wk26 time point)
7L89 7L89 BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.32034 (Wk26 time point)
7L88 7L88 BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.32034 (Wk26 time point)
7L87 7L87 BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.32034 (Wk26 time point)
7L86 7L86 BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.32034 (Wk26 time point)
7L7U 7L7U BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component B)
7L7T 7L7T BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component A)
7L7R 7L7R CCHFV Gc prefusion monomer bound to ADI-36121 and ADI-37801 Fabs
7L7R Q8JSZ3 CCHFV Gc prefusion monomer bound to ADI-36121 and ADI-37801 Fabs
7L7E 7L7E Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061
7L7E P0DTC2 Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061
7L7D P0DTC2 Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895
7L7D 7L7D Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895
7L74 Q564N5 Crystal structure of Beta-hexosyl transferase from Hamamotoa (Sporobolomyces) singularis bound to TRIS
7L6T P0DTD1 Crystal Structure of SARS-CoV-2 Nsp16/10 Heterodimer in Complex with (m7GpppA2m)pUpUpApApA (Cap-1), S-Adenosyl-L-homocysteine (SAH) and two Magnesium (Mg) ions.
7L6R P0DTD1 Crystal Structure of SARS-CoV-2 Nsp16/10 Heterodimer in Complex with (m7GpppA2m)pUpUpApApA (Cap-1), S-Adenosyl-L-homocysteine (SAH) and Manganese (Mn).
7L6O A0A1W6IPB2 Cryo-EM structure of HIV-1 Env CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 - gp120, CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 - gp41
7L6O 7L6O Cryo-EM structure of HIV-1 Env CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 - gp120, CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 - gp41
7L67 P22897 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Fuc-(alpha1-3)-GlcNAc
7L66 P22897 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Methyl-GlcNAc
7L65 P22897 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Methyl-GlcNAc
7L64 P22897 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Lewis-a
7L63 P22897 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose
7L62 P22897 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose
7L61 P22897 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose
7L5K A0A768MZ64 Crystal structure of the DiB-RM protein
7L58 P0DTC2 Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4 Spike glycoprotein, Fab H4 variable domain heavy chain, Fab H4 variable domain light chain
7L58 7L58 Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4 Spike glycoprotein, Fab H4 variable domain heavy chain, Fab H4 variable domain light chain
7L57 P0DTC2 Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15 Spike glycoprotein, Fab 2-15 variable domain heavy chain, Fab 2-15 variable domain light chain
7L57 7L57 Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15 Spike glycoprotein, Fab 2-15 variable domain heavy chain, Fab 2-15 variable domain light chain
7L56 P0DTC2 Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43
7L56 7L56 Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43
7L4Z P0DTC2 Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide
7L4Z 7L4Z Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide
7L3N P0DTC2 SARS-CoV 2 Spike Protein bound to LY-CoV555 Spike glycoprotein, LY-CoV555 Fab heavy chain, LY-CoV555 Fab light chain
7L3N 7L3N SARS-CoV 2 Spike Protein bound to LY-CoV555 Spike glycoprotein, LY-CoV555 Fab heavy chain, LY-CoV555 Fab light chain
7L31 P23416 Cyro-EM structure of human Glycine Receptor alpha2-beta heteromer, strychnine bound state, 3.8 Angstrom
7L31 P42212 Cyro-EM structure of human Glycine Receptor alpha2-beta heteromer, strychnine bound state, 3.8 Angstrom
7L31 P48167 Cyro-EM structure of human Glycine Receptor alpha2-beta heteromer, strychnine bound state, 3.8 Angstrom
7L2F P0DTC2 Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
7L2F 7L2F Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
7L2E P0DTC2 Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein
7L2E 7L2E Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024